| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.977 | 12.003 | 6.444 | 7.149 | 7.793 | 5.983 | 7.060 | 4.411 | 0 | 4.501 |
| Total Income - EUR | 12.871 | 12.800 | 7.042 | 7.424 | 8.882 | 6.930 | 7.607 | 5.537 | 1.242 | 4.627 |
| Total Expenses - EUR | 5.533 | 5.931 | 4.589 | 6.016 | 6.384 | 6.608 | 6.705 | 6.994 | 7.339 | 9.536 |
| Gross Profit/Loss - EUR | 7.338 | 6.869 | 2.453 | 1.408 | 2.498 | 321 | 902 | -1.457 | -6.097 | -4.908 |
| Net Profit/Loss - EUR | 6.952 | 6.482 | 2.016 | 1.193 | 2.265 | 142 | 691 | -1.586 | -6.097 | -4.908 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmacia Elixir S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 23.186 | 21.022 | 18.599 | 16.229 | 13.925 | 11.709 | 9.541 | 7.656 | 5.724 | 3.794 |
| Current Assets | 30.604 | 21.877 | 16.248 | 25.131 | 29.131 | 26.671 | 24.197 | 22.913 | 17.243 | 9.179 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 8.007 | 2.158 | 1.346 | 10.654 | 10.448 | 10.250 | 10.673 | 10.058 | 10.027 | 0 |
| Cash | 12 | -890 | 432 | 2.745 | 8.515 | 7.280 | 5.557 | 6.242 | 2.997 | 6.103 |
| Shareholders Funds | 33.683 | 32.941 | 28.027 | 34.962 | 36.550 | 31.657 | 27.189 | 22.706 | 16.498 | 11.497 |
| Social Capital | 450 | 445 | 438 | 430 | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | 20.107 | 9.958 | 6.820 | 6.398 | 6.507 | 6.723 | 6.549 | 7.862 | 6.469 | 1.475 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Elixir S.r.l.